ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 1 filers reported holding ZEALAND PHARMA A S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,869,000 | -16.6% | 220,523 | -0.4% | 0.00% | – |
| Q1 2022 | $3,442,000 | +6.9% | 221,369 | +46.7% | 0.00% | – |
| Q4 2021 | $3,221,000 | -27.6% | 150,946 | -0.1% | 0.00% | – |
| Q3 2021 | $4,449,000 | +36975.0% | 151,134 | +37873.4% | 0.00% | – |
| Q2 2021 | $12,000 | -45.5% | 398 | -42.7% | 0.00% | – |
| Q1 2021 | $22,000 | +46.7% | 694 | +70.5% | 0.00% | – |
| Q4 2020 | $15,000 | +25.0% | 407 | +30.9% | 0.00% | – |
| Q3 2020 | $12,000 | 0.0% | 311 | -10.6% | 0.00% | – |
| Q2 2020 | $12,000 | -25.0% | 348 | -24.8% | 0.00% | – |
| Q1 2020 | $16,000 | -5.9% | 463 | -10.4% | 0.00% | – |
| Q4 2019 | $17,000 | +70.0% | 517 | +35.7% | 0.00% | – |
| Q3 2019 | $10,000 | +11.1% | 381 | -7.1% | 0.00% | – |
| Q2 2019 | $9,000 | +350.0% | 410 | +177.0% | 0.00% | – |
| Q4 2018 | $2,000 | +100.0% | 148 | +196.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 50 | -40.5% | 0.00% | – |
| Q2 2018 | $1,000 | -92.9% | 84 | -90.4% | 0.00% | – |
| Q1 2018 | $14,000 | – | 875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 750,000 | $25,875,000 | 0.22% |
| AWM Investment Company, Inc. | 19,981 | $689,000 | 0.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 5,653 | $183,000 | 0.08% |
| OLD MISSION CAPITAL LLC | 15,890 | $548,000 | 0.05% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,433,091 | $49,442,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 10,000 | $345,000 | 0.01% |
| STATE OF WISCONSIN INVESTMENT BOARD | 44,092 | $1,521,000 | 0.01% |
| Rockefeller Capital Management L.P. | 8,876 | $306,000 | 0.00% |
| Winslow, Evans & Crocker, Inc. | 236 | $10,000 | 0.00% |
| Filbrandt Wealth Management, LLC | 25 | $1,000 | 0.00% |